MCSVX
MainStay MacKay Convertible Fund Class B
$18.68
MainStay MacKay Convertible Fund Class B (MCSVX)
The fund seeks to achieve both capital growth and a consistent income stream. Typically, at least 80% of its total assets—calculated as net assets plus any borrowed funds for investment—are committed to "convertible securities." Such investments, which include bonds, debentures, corporate notes, and preferred stocks, offer the option to convert into common stock or the cash equivalent of a stock, or even a basket or index of equity securities. The balance of the portfolio may be held in other assets, such as non-convertible debt, non-dividend-paying equity securities, U.S. government securities, or cash and its equivalents.
MCSVX Mutual Fund Chart & Stats
$18.68
At close: 4:00 PM EST- Previous Close
- $18.68
- Sub-Category
- Convertible Bonds and Debt
- Total Liabilities
- $7.52M
- Last Dividend Ex-Date
- Dec 16, 2024
- Expense Ratio
- 1.94%
- Holding Count
- 106
- Brand
- New York Life Investments Funds
- Dividend Yield
- (2.11%)
- Category
- Fixed-Income
- Total Assets
- 1.59B
- Shares Outstanding
- N/A
- 52-Week Range
- $18.68 - $18.68
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHNYLI U.S. Government Liquidity Fund | 6.05% |
| USD_CASHNRG Energy, Inc. | 2.21% |
| USD_CASHLantheus Holdings, Inc. | 2.05% |
| USD_CASHMerit Medical Systems, Inc. | 2.05% |
| USD_CASHTetra Tech, Inc. | 1.90% |
| USD_CASHInteger Holdings Corp. | 1.87% |
| USD_CASHExact Sciences Corp. | 1.83% |
| USD_CASHCarnival Corp. | 1.81% |
| USD_CASHSouthwest Airlines Co. | 1.74% |
| USD_CASHBioMarin Pharmaceutical, Inc. | 1.71% |
| Total | 23.22% |
Recently Viewed
No data currently available

